Tag: Casirivimab/imdevimab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Casirivimab/imdevimab

Therapeutics and COVID-19 (Living Guideline, 14 July 2022) - World | ReliefWeb

Added to Collection on: 2022-07-14 23:58:29

Tags for this article:

Health sciences
COVID-19 drug development
Health
Drugs
Monoclonal antibodies
Occupational safety and health
Treatment and management of COVID-19
Casirivimab/imdevimab
COVID-19
SARS-CoV-2 Omicron variant
Ritonavir
COVID-19 drug repurposing research

Click the tags to see associated articles and topics

View Article Details
Regeneron ends four clinical trials of its rolled back Covid-19 antibody – Endpoints News

Added to Collection on: 2022-08-01 20:26:54

Tags for this article:

Monoclonal antibodies
Medical specialties
Life Sciences
Drugs
COVID-19 drug development
Casirivimab/imdevimab
Roche
Immunology
Regeneron Pharmaceuticals
Bamlanivimab
Treatment and management of COVID-19
Regeneron

Click the tags to see associated articles and topics

View Article Details
Covid-19 Treatment Medicine Market Growth 2022-2028: Pfizer (Paxlovid), VEKLURY ...

Added to Collection on: 2022-09-04 06:57:16

Tags for this article:

COVID-19 drug development
Life Sciences
Drugs
Health sciences
Monoclonal antibodies
Antiviral drugs
Casirivimab/imdevimab
Roche
Pfizer
Remdesivir
Regeneron Pharmaceuticals
Pharmaceutical industry

Click the tags to see associated articles and topics

View Article Details
Press Release: Dupixent® (dupilumab) Phase 3 Results show - GlobeNewswire

Added to Collection on: 2023-10-22 19:23:08

Tags for this article:

Sanofi
Monoclonal antibodies
Breakthrough therapy
Food and Drug Administration
Dupilumab
Eosinophilic esophagitis
Regeneron Pharmaceuticals
Prurigo nodularis
Priority review
Casirivimab/imdevimab
Esophagitis
Atopic dermatitis

Click the tags to see associated articles and topics

View Article Details
COVID drugs more often given to Medicare patients who least need them, study suggests

Added to Collection on: 2024-01-26 21:57:52

Tags for this article:

COVID-19 drug development
Treatment and management of COVID-19
Nirmatrelvir/ritonavir
Bamlanivimab
Casirivimab/imdevimab
Sotrovimab
Molnupiravir
Remdesivir
Nirmatrelvir
COVID-19
COVID-19 drug repurposing research
Coronavirus spike protein

Click the tags to see associated articles and topics

View Article Details
New Monoclonal Authorized to Prevent COVID in Immunocompromised People

Added to Collection on: 2024-03-22 22:50:07

Tags for this article:

COVID-19 drug development
Monoclonal antibodies
Immunology
AstraZeneca
Tixagevimab/cilgavimab
COVID-19
Post-exposure prophylaxis
Variants of SARS-CoV-2
Cytokine release syndrome
Casirivimab/imdevimab
Bamlanivimab/etesevimab

Click the tags to see associated articles and topics

View Article Details
Roche warns 2023 profits will fall on $5 billion COVID sales hit - Yahoo Movies UK

Added to Collection on: 2024-05-03 14:42:05

Tags for this article:

Roche
Severin Schwan
Pharmaceutical industry in China
Casirivimab/imdevimab
gsk plc
Bill Anderson
Siemens Healthineers
Swiss franc
Ludwig Burger
Roche Group

Click the tags to see associated articles and topics

View Article Details
Monoclonal Antibody Combination Improves HRQOL in Patients With COVID-19

Added to Collection on: 2024-10-15 14:33:43

Tags for this article:

Clinical research
COVID-19 drug development
Medical terminology
Mind?body interventions
Vaccine-preventable diseases
Casirivimab/imdevimab
Patient-reported outcome
Quality of life
SARS-CoV-2 Omicron variant
EQ-5D
Sertraline
Placebo
Mab

Click the tags to see associated articles and topics

View Article Details
FDA Revokes EUAs of Four COVID-19 Monoclonal Antibodies | MedPage Today

Added to Collection on: 2024-12-13 23:04:03

Tags for this article:

COVID-19 drug development
Monoclonal antibodies
Antiviral drugs
Casirivimab/imdevimab
Immune system
Tixagevimab/cilgavimab
Sotrovimab
Bebtelovimab
Regeneron Pharmaceuticals
ATC code J06

Click the tags to see associated articles and topics

View Article Details
Regeneron settles patent lawsuit over protein for testing COVID-19 treatments - TradingView

Added to Collection on: 2024-12-16 20:34:57

Tags for this article:

Monoclonal antibodies
Regeneron Pharmaceuticals
Casirivimab/imdevimab
Pfizer
COVID-19 vaccine
Pharmaceutical industry in India
Patent infringement
George Yancopoulos
Evolocumab
Regeneron Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details